DURO, GIOVANNI
 Distribuzione geografica
Continente #
AS - Asia 2.823
NA - Nord America 1.658
EU - Europa 869
SA - Sud America 490
AF - Africa 47
OC - Oceania 9
Totale 5.896
Nazione #
US - Stati Uniti d'America 1.573
SG - Singapore 1.148
CN - Cina 677
BR - Brasile 385
IT - Italia 313
VN - Vietnam 295
HK - Hong Kong 253
FR - Francia 158
NL - Olanda 132
KR - Corea 106
BD - Bangladesh 101
JP - Giappone 64
GB - Regno Unito 63
DE - Germania 56
IN - India 47
CA - Canada 43
FI - Finlandia 37
AR - Argentina 35
MX - Messico 20
EC - Ecuador 19
ID - Indonesia 18
IQ - Iraq 17
PL - Polonia 17
TR - Turchia 16
ES - Italia 13
IL - Israele 13
ZA - Sudafrica 13
CL - Cile 12
EG - Egitto 10
RU - Federazione Russa 10
AU - Australia 9
CO - Colombia 8
SA - Arabia Saudita 8
SE - Svezia 8
UA - Ucraina 8
PE - Perù 7
PK - Pakistan 7
PY - Paraguay 7
VE - Venezuela 7
DZ - Algeria 6
JM - Giamaica 6
LT - Lituania 6
MA - Marocco 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
BO - Bolivia 5
GT - Guatemala 5
PH - Filippine 5
AZ - Azerbaigian 4
BE - Belgio 4
CZ - Repubblica Ceca 4
GR - Grecia 4
JO - Giordania 4
KZ - Kazakistan 4
LB - Libano 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
BG - Bulgaria 3
NP - Nepal 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CH - Svizzera 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
IE - Irlanda 2
LV - Lettonia 2
NI - Nicaragua 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LS - Lesotho 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
Totale 5.892
Città #
Singapore 690
Santa Clara 484
Hefei 247
Hong Kong 246
San Jose 209
Ashburn 137
Lauterbourg 128
Beijing 118
Seoul 101
Ho Chi Minh City 99
Los Angeles 82
Hanoi 73
Tokyo 49
Dallas 44
New York 27
São Paulo 27
Buffalo 26
Guangzhou 25
Frankfurt am Main 24
Orem 21
Helsinki 19
Naples 19
Rome 19
Council Bluffs 17
Lappeenranta 17
Milan 17
Da Nang 15
London 15
Rio de Janeiro 13
Curitiba 12
Minamishinagawa 12
Palermo 12
Brasília 11
Düsseldorf 11
Haiphong 11
Montreal 11
Ninh Bình 11
Warsaw 11
Atlanta 10
Florence 10
Bengaluru 9
Brooklyn 9
Campinas 9
Chennai 9
Elk Grove Village 9
Houston 9
Hyderabad 9
Toronto 9
Boardman 8
Cairo 8
Mexico City 8
Phoenix 8
Stockholm 8
Bari 7
Charlotte 7
Amsterdam 6
Ankara 6
Baghdad 6
Guayaquil 6
Munich 6
Padua 6
Quito 6
Salvador 6
Tashkent 6
Belo Horizonte 5
Biên Hòa 5
Blumenau 5
Buenos Aires 5
Johannesburg 5
Porto Alegre 5
Portsmouth 5
Redondo Beach 5
Ribeirão Preto 5
Thái Bình 5
Vũng Tàu 5
Aparecida de Goiânia 4
Austin 4
Baku 4
Boston 4
Bắc Ninh 4
Catania 4
Dhaka 4
Erbil 4
Falkenstein 4
Guatemala City 4
Hải Dương 4
Kingston 4
Lima 4
Madrid 4
Messina 4
Newark 4
Nuremberg 4
Paris 4
Riyadh 4
San Francisco 4
Santiago 4
Santo André 4
Sydney 4
São Bernardo do Campo 4
Thái Nguyên 4
Totale 3.465
Nome #
Sex Differences in Anderson-Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women 120
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease 110
Expanded screening for Fabry disease in patients with chronic kidney disease not on dialysis: a multicenter Italian experience 106
miR-126-3p and miR-21-5p as Hallmarks of Bio-Positive Ageing; Correlation Analysis and Machine Learning Prediction in Young to Ultra-Centenarian Sicilian Population 103
Highlights of Precision Medicine, Genetics, Epigenetics and Artificial Intelligence in Pompe Disease 93
Molecular and clinical studies in five index cases with novel mutations in the GLA gene. 82
Can Be miR-126-3p a Biomarker of Premature Aging? An Ex Vivo and In Vitro Study in Fabry Disease 81
Diagnosis of Fabry Disease Using Alpha-Galactosidase A Activity or LysoGb3 in Blood Fails to Identify Up to Two Thirds of Female Patients 80
Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease? 79
The Identification of a Novel Pathogenic Variant of the GLA Gene Associated with a Classic Phenotype of Anderson–Fabry Disease: A Clinical and Molecular Study 77
Early Cardiac involvement affects left ventricular longitudinal function in females carrying ?- galactosidase a mutation role of hybrid positron emission tomography and magnetic resonance imaging and speckle-tracking echocardiography 75
Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significance 74
Pompe disease: pathogenesis, molecular genetics and diagnosis 73
A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report 73
A novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema 71
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 71
Transforming Growth Factor 1 T29c Gene Polymorphism And Hypertension: Relationship With Cardiovascular And Renal Damage 70
Hemochromatosis Mimicked Gaucher Disease: Role of Hyperferritinemia in Evaluation of a Clinical Case 70
Fabry Disease and Inflammation: Potential Role of p65 iso5, an Isoform of the NF-κB Complex 69
Mutation Spectrum of GAA Gene in Pompe Disease: Current Knowledge and Results of an Italian Study 68
Polymorphisms in the intergenic region of the sea urchin Paracentrotus lividus ribosomal DNA 67
Late-Onset Pompe Disease with Normal Creatine Kinase Levels: The Importance of Rheumatological Suspicion 67
Calnexin is down-regulated in Fabry disease. A possible implication in protein misfolding 66
Gaucher Disease or Acid Sphingomyelinase Deficiency? The Importance of Differential Diagnosis 64
Identification of Novel Mutations in Patients Affected by Gaucher Disease 63
Translation of Basic Research into Clinics: Killer Immunoglobulin-like Receptors Genes in Autoimmune and Infectious Diseases 62
Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area 62
Myocardial dysfunction in Anderson-Fabry disease (AFD) without ventricular hypertrophy 62
Simple and inexpensive dot-blot apparatus 61
De novo mutation in a male patient with Fabry disease: a case report 59
Newborn screening for fabry disease in northeastern italy: Results of five years of experience 58
Up-regulation of gamma-enolase in PMC from Fabry patients 57
European Biotech week 54
A pilot study of circulating microRNAs as potential biomarkers of Fabry disease 54
Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study 54
A new p65 isoform that bind the glucocorticoid hormone and is expressed in inflammation liver diseases and COVID-19 53
Misdiagnosi di Febbre Mediterranea Familiare in pazienti con Malattia di Anderson-Fabry 53
HLA-C1 ligands are associated with increased susceptibility to systemic lupus erythematosus 52
Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: preliminary findings. 52
Fabry disease, a complex pathology not easy to diagnose 52
Blood group does not appear to affect longevity a pilot study in centenarians from Western Sicily. 51
Case report: De novo mutation of a-galactosidase A in a female patient with end-stage renal disease: report of a case of late diagnosis of Anderson–Fabry disease 51
Age-related inflammation: the contribution of different organs, tissues and systems. how to face it for therapeutic approaches. 48
Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: preliminary findings 48
Fabry disease and multiple sclerosis misdiagnosis: the role of family history and neurological signs. 45
Circulating miRNAs in Successful and Unsuccessful Aging. A Mini-review 45
Fabry Disease Beyond Storage: The Role of Inflammation in Disease Progression 45
High variability of fabry disease manifestations in an extended italian family 43
Fabry disease: a proteomic approach 43
Analysis of mutations in the GLA and MEFV genes might determines a genetic variant of Fabry diseases 42
Proteomic approach in Fabry disease: a case report 41
GM Allotypes and COVID-19. A Pilot Study Performed on Sicilian Patients. 41
Identification of cross-reactive and genuine Parietaria judaica pollen allergens 41
DNA methylation impact on Fabry disease 41
Identification of a novel mutation in the alpha-galactosidase A gene in patients with Fabry disease 40
Novel alpha-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease 40
Misdiagnosis of familial Mediterranean fever in patients with Anderson-Fabry disease 40
null 40
Distribution of KIR Genes and Their HLA Ligands in Different Viral Infectious Diseases: Frequency Study in Sicilian Population 40
Immune-inflammatory responses and oxidative stress in Alzheimer' disease: therapeutic implications 39
KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection 39
Novel alpha-galactosidase A mutation in a female with recurrent strokes. 39
A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha galactosidase A gene 38
Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation? 38
The historical relevance of urine and the future implications 38
Mucopolysaccharidosis Type I and α-Mannosidosis—Phenotypically Comparable but Genetically Different: Diagnostic and Therapeutic Considerations 38
Alterazioni introniche in soggetti con sintomatologia riconducibile alla malattia di Fabry 38
HLA and Killer Cell Immunoglobulin-like Receptors Influence the Natural Course of CMV Infection. 37
Genetic screening of Fabry patients with EcoTILLING and HRM technology 37
Parietaria judaica ns-LTP antigen variants, uses thereof and compositions comprising them 36
Assignment of disulphide bridges in Parj 2.0101, a major allergen of Parietaria judaica pollen 35
Multiplex Ligation Probe Amplification and Sanger Sequencing: Light and Shade in the Diagnosis of Lysosomal Storage Disorders 35
Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: A comparative study 35
Healthy ageing and Mediterranean diet: A focus on hormetic phytochemicals 35
How Important Are Genes to Achieve Longevity? 35
VEXAS Syndrome: Genetics, Gender Differences, Clinical Insights, Diagnostic Pitfalls, and Emerging Therapies 34
Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease 34
Hypoallergenic fragment of Par j 2 increases functional expression of Toll-like receptors in atopic children 33
An update on allergens. Parietaria pollen allergens. 33
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis 33
Ambiente e Salute: dal monitoraggio aerobiologico alla prevenzione 32
Parietaria pollen allergens: a model to study the Type I allergy 32
Use of a pure allergen component 32
Readthrough transcription occurs at the rho dependent signal F1 TIV in suppressor cells 30
Peptidi derivati dall'allergene par j 2 del polline di parietaria judaica 30
Hypoadiponectinemia, cardiometabolic comorbidities and left ventricular hypertrophy 30
Severe hypertrophic cardiomyopathy in a patient with atypical Anderson-Fabry disease. 30
A method for eluting DNA in a wide range of molecular weights from agarose gels 30
Varianti di allergeni NS-LTPS, loro usi e composti che le comprendono 30
Germline mosaicism for the c.2021G>A (p.Arg674Gln) mutation in siblings with trismus pseudocamptodactyly. 29
Response to Simsek et al. 29
Intragenomic recombination between homologous regions of genes II and IV promotes formation of bacteriophage f1 miniphages 29
IDENTIFICATION OF AN IMMUNODOMINANT IGE EPITOPE OF THE PARIETARIA JUDAICA MAJOR ALLERGEN. 29
The signature of longevity in Sicily 28
Genotypic and phenotypic aspects of longevity: Results from a sicilian survey and implication for the prevention and treatment of age-related diseases 28
cDNA cloning, sequence analysis and allergological characterization of Par j 2.0101, a new major allergen of the Parietaria judaica pollen 28
Isolation of proteins and nucleic acids by electrophoresis on disposable gel columns 27
Voltage gradient electrophoresis of nucleic acids on agarose gels 27
Lack of major differences between the sequences of 26S ribosomal RNAs from eggs and intestines of sea urchin 27
Identification of an Immunodominant IgE Epitope of the Parietaria judaica Major Allergen 27
Totale 4.985
Categoria #
all - tutte 20.613
article - articoli 18.051
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 105
Totale 38.769


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202436 0 0 0 0 0 0 0 0 4 0 26 6
2024/20252.237 79 11 160 74 467 71 12 128 114 147 524 450
2025/20263.658 173 288 332 542 658 132 480 172 206 283 270 122
2026/2027116 116 0 0 0 0 0 0 0 0 0 0 0
Totale 6.047